AAAAAA

   
Results: 1-2 |
Results: 2
INCREASED DOSE INTENSITY (DI) OF DOXORUBICIN AND VINBLASTINE DURING ABVD THERAPY OF HODGKINS LYMPHOMA WITH THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR (GCSF)
Authors: RAYBON K SCHROEDER M ALLERTON J
Citation: K. Raybon et al., INCREASED DOSE INTENSITY (DI) OF DOXORUBICIN AND VINBLASTINE DURING ABVD THERAPY OF HODGKINS LYMPHOMA WITH THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR (GCSF), Blood, 86(10), 1995, pp. 3270-3270
BONE-MARROW TRANSPLANTATION (BMT) IN MULTIPLE-MYELOMA (MM) WITH BUSULFAN (BU) AND CYCLOPHOSPHAMIDE (CY) - UNACCEPTABLE TOXICITY WITH STANDARD-DOSE IN HEAVILY PRETREATED PATIENTS
Authors: RAYBON K THOMAS A SCHROEDER M LEWIS S CHRISTMAN K WILKS S OSSWALD M ABBOTT K HALVORSON R ESSELL J ALLERTON J
Citation: K. Raybon et al., BONE-MARROW TRANSPLANTATION (BMT) IN MULTIPLE-MYELOMA (MM) WITH BUSULFAN (BU) AND CYCLOPHOSPHAMIDE (CY) - UNACCEPTABLE TOXICITY WITH STANDARD-DOSE IN HEAVILY PRETREATED PATIENTS, Blood, 86(10), 1995, pp. 3833-3833
Risultati: 1-2 |